Organization

Siteman Cancer Center, Washington University School of Medicine

2 abstracts

Abstract
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in combination with gemcitabine and docetaxel in non-small cell and small cell lung cancers.
Org: Department of Oncology, Washington University School of Medicine, Siteman Cancer Center, Washington University School of Medicine, Polaris Pharmaceuticals Inc., Division of Medical Oncology, Washington University in St. Louis,
Abstract
Integration of clinical trial development in hematology and oncology fellowship training: Washington University School of Medicine experience.
Org: Washington University School of Medicine in St. Louis, Washington University School of Medicine in St Louis, Washington University in St. Louis, A2 Biotherapeutics, Inc., Siteman Cancer Center, Washington University School of Medicine,